初次二叶主动脉瓣置换时开放半弓与阻断升主动脉置换的对比
该回顾性队列纳入702例初次非急诊原生二叶主动脉瓣置换同期升主动脉置换患者,比较开放半弓置换(n=225)与阻断升主动脉置换(n=477)。半弓组体外循环时间更长且输血风险增加,但两组并发症、死亡率和生存率相似,随访期间无因主动脉病再次弓部手术。
要点
- 半弓置换较阻断升主动脉置换体外循环时间显著延长(188 vs 97分钟,P<.001)。
- 半弓组输血风险增加(OR 1.62,95%CI 1.15-2.28,P=.006),但并发症与死亡率相似。
- 两组生存率相似(HR 0.83,95%CI 0.51-1.33,P=.439),随访期无再次弓部手术。
核心结论
- 在无主动脉弓扩张的情况下,半弓置换未显示优于阻断升主动脉置换的临床获益。
研究设计与样本
- 回顾性队列研究,纳入2000年1月至2017年6月单中心702例初次非急诊原生二叶主动脉瓣置换同期升主动脉置换患者。
- 半弓置换组225例(32%),阻断升主动脉置换组477例(68%)。
主要发现
- 中位年龄60岁(IQR 51-67),女性113例(16%),射血分数62%(IQR 56%-66%),主动脉弓直径33 mm(IQR 29-36 mm)。
- 半弓组体外循环时间188分钟 vs 97分钟(P<.001)。
- 手术相关并发症36%,死亡率<1%,两组相似;半弓组输血几率增加(OR 1.62,95%CI 1.15-2.28,P=.006)。
- 中位随访6.0年(95%CI 5.3-6.8年),5年生存率94±1%,10年生存率80±2%。
- 多变量分析显示两组生存相似(HR 0.83,95%CI 0.51-1.33,P=.439),随访期间无因主动脉病再次弓部手术。
临床怎么用
- 对于二叶主动脉瓣相关主动脉病需行升主动脉置换者,若主动脉弓无扩张,可考虑阻断升主动脉置换以缩短体外循环时间并降低输血风险。
局限性
- 回顾性单中心设计,可能存在选择偏倚和未测量混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is controversy regarding the extent of aortic resection necessary in patients with aortopathy related to bicuspid aortic valve disease. To address this issue, we reviewed our experience in patients undergoing ascending aorta replacement during bicuspid aortic valve replacement. METHODS: We reviewed 702 patients who underwent ascending aorta replacement at the time of initial nonemergent native bicuspid aortic valve replacement at our institution between January 2000 and June 2017. Treatment cohorts included an open hemiarch replacement group (n = 225; 32%) and a clamped ascending aorta replacement group (n = 477; 68%). RESULTS: Median patient age was 60 years (interquartile range [IQR], 51-67 years), female sex was present in 113 patients (16%), ejection fraction was 62% (IQR, 56%-66%), and aortic arch diameter was 33 mm (IQR, 29-36 mm). Cardiopulmonary bypass time was longer in the hemiarch replacement group (188 minutes vs 97 minutes; P < .001). Procedure-related complications (36%) and mortality (<1%) were similar in the 2 groups; however, the hemiarch group had an increased odds of blood transfusion (odds ratio, 1.62; 95% confidence interval [CI], 1.15-2.28; P = .006). The median duration of follow-up was 6.0 years (95% CI, 5.3-6.8 years). Overall survival was 94 ± 1% at 5 years and 80 ± 2% at 10 years. Multivariable analysis demonstrated similar survival in the 2 groups (hazard ratio, 0.83; 95% CI, 0.51-1.33; P = .439). No repeat aortic arch operations were done for aortopathy over the duration of clinical follow-up. CONCLUSIONS: Compared with patients in the clamped ascending aorta replacement group, patients in the hemi-arch replacement group had longer cardiopulmonary bypass and aortic cross-clamp times, along with an increased risk of blood transfusion, but similar freedom from repeat aortic arch operation and survival. We identified no advantage of performing hemiarch replacement in the absence of aortic arch dilation.
引用
- Greason KL, Crestanello JA, King KS, et al. Open hemiarch versus clamped ascending aorta replacement for aortopathy during initial bicuspid aortic valve replacement. J Thorac Cardiovasc Surg. 2019. PMID: 31757461. doi:10.1016/j.jtcvs.2019.09.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。